The SPDR S&P Biotech ETF is up about 3.6% on the day, indicating strong risk-on flows into the biotech sector. Apogee Therapeutics is a standout mover, surging 46.8%, while Oruka Therapeutics is up 18.1%. The article reflects broad sector strength led by sharp gains in individual biotech names.
The SPDR S&P Biotech ETF is up about 3.6% on the day, indicating strong risk-on flows into the biotech sector. Apogee Therapeutics is a standout mover, surging 46.8%, while Oruka Therapeutics is up 18.1%. The article reflects broad sector strength led by sharp gains in individual biotech names.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.74
Ticker Sentiment
